… This makes ovarian cancer the fifth most common cancer among women in Germany, …
cancer, with 4.8% of cases. 70% of cases of ovarian cancer are not diagnosed until the cancer has …

… ovarian cancer … in ovarian cancer, as it is used not only for diagnosis and staging but also
therapeutically, even in patients with widely disseminated, advanced disease. Ovarian cancer …

… after initial diagnosis of ovarian cancer has been … ovarian cancer; late diagnosis, which
poses difficulty in designing an intervention; and the development of chemoresistance in cancer …

… In this study we investigated the diagnosis of breast and ovarian cancer in relation to … of all
incidental cancers in a well-defined population. Negative prognostic predictors for crude, but …

… that had been isolated from the serum of ovarian cancer patients with those from matched
tumor … plasma for use as diagnostic and prognostic biomarkers in ovarian cancer. We sought to …

… ovarian cancer outcomes unit of the british columbia cancer agency. Tumor cell type can be
reproducibly diagnosed and is of independent prognostic … ovarian carcinoma. Hum. Pathol. …

… This review provides a glance at the latest advances in AI-assisted diagnosis and prognostic
prediction of ovarian cancer (OC). We performed an advanced search in PubMed and IEEE/…

… cancers. The present study investigated the prognostic role of GGT in ovarian cancer … To
better characterise the role of GGT in ovarian cancer we also investigated GGT serum levels of …

… Therefore, this review highlights current evidence based updated ovarian cancer specific
prognostic and diagnostic biomarkers and potential importance of CSCs in context of …

… levels of proteins between ovarian cancer and normal ovarian tissue. Our results indicate …
in ovarian cancer and upregulated expression of legumain increases ovarian cancer cell …